FI85106B - Foerfarande foer framstaellning av ett transdermalt doseringssystem. - Google Patents

Foerfarande foer framstaellning av ett transdermalt doseringssystem. Download PDF

Info

Publication number
FI85106B
FI85106B FI861177A FI861177A FI85106B FI 85106 B FI85106 B FI 85106B FI 861177 A FI861177 A FI 861177A FI 861177 A FI861177 A FI 861177A FI 85106 B FI85106 B FI 85106B
Authority
FI
Finland
Prior art keywords
adhesive
pharmaceutically active
layer
active drug
component layer
Prior art date
Application number
FI861177A
Other languages
English (en)
Finnish (fi)
Other versions
FI861177A0 (fi
FI85106C (sv
FI861177A (fi
Inventor
Steven Sablotsky
John M Questel
James A Thompson
Original Assignee
Key Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24541997&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI85106(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Key Pharma filed Critical Key Pharma
Publication of FI861177A0 publication Critical patent/FI861177A0/fi
Publication of FI861177A publication Critical patent/FI861177A/fi
Application granted granted Critical
Publication of FI85106B publication Critical patent/FI85106B/fi
Publication of FI85106C publication Critical patent/FI85106C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Claims (8)

1. Förfarande för framställning av ett adhesivt transdermalt doseringsskikt avsett för fördröjd frigöring 5 av ett farmaceutiskt ämne, kännetecknat där- av, att a) man blandar ett akryliskt adhesivt ämne och vetten tili en homogen blandning; b) man sätter det farmaceutiskt aktiva läkemedlet 10 tili den homogena blandningen; c) man bildar en jämn homogen blandning av det farmaceutiskt aktiva läkemedlet och den homogena blandningen; d) man tillsätter ett tvärbindningsmedel för det akryliska adhesiva ämnet tili den erhällna jämna homogena 15 blandningen; e) man utför tvärbindningen mellan det tvärbindande ämnet och det akryliska adhesiva ämnet; och f) man avlägsnar tillräckligt med vatten och lös-ningsmedel ur produkten frän steg e) varvid ett adhesivt 20 transdermalt skikt bildas.
2. Förfarande för framställning av ett adhesivt transdermalt doseringsskikt enligt patentkravet 1, kännetecknat därav, att det farmaceutiskt aktiva ämnet är ett vasodilatoriskt ämne. 25
3. Förfarande för framställning av ett adhesivt transdermalt doseringsskikt enligt patentkravet 2, kännetecknat därav, att det vasodilatoriska ämnet är nitroglycerin.
4. Förfarande för framställning av ett adhesivt 30 transdermalt doseringsskikt enligt patentkravet 3, kännetecknat därav, att den närvarande nitro-glycerinmängden utgör 20 - 50 vikt-% beräknat pä vikten av det adhesiva transdermala doseringsskiktet. 21 85106
5. Förfarande för framställning av ett adhesivt transdermalt tväskikts doseringssystem avsett för fördröjd frigöring av ett farmaceutiskt ämne, känneteck-n a t därav, att 5 a) man blandar ett akryliskt adhesivt ämne och vet ten tili en homogen blandning; b) man sätter det farmaceutiskt aktiva läkemedlet tili den homogena blandningen; c) man bildar en jämn homogen blandning av det far-10 maceutiskt aktiva läkemedlet och den homogena blandningen; d) man tillsätter ett tvärbindningsmedel för det akryliska adhesiva ämnet tili den erhällna jämna homogena blandningen; e) man utför tvärbindningen mellan det tvärbindande 15 ämnet och det akryliska adhesiva ämnet; f) man applicerar det frän sted e) erhällna tvär-bundna akryliska adhesiva skiktet pä ett andra skikt; och g) man avlägsnar tillräckligt med vatten och lös-ningsmedel ur det tvärbundna akryliska adhesiva skiktet, 20 varvid ett transdermalt tväskiktsdoseringssystem bildas.
6. Förfarande enligt patentkravet 5, känne-t e c k n a t därav, att det farmaceutiskt aktiva ämnet är ett vasodilatorisk ämne.
7. Förfarande enligt patentkravet 6, känne-25 tecknat därav, att det vasodilatoriska ämnet är nitroglycerin.
8. Förfarande enligt patentkravet 7, känne-tecknat därav, att den närvarande nitroglycerin-mängden utgör 20 - 50 vikt-% beräknat pä vikten av det 30 adhesiva transdermala tväskiktsdoseringssystemet.
FI861177A 1984-07-24 1986-03-20 Förfarande för framställning av ett transdermalt doseringssystem FI85106C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63399284A 1984-07-24 1984-07-24
US63399284 1984-07-24
US8501401 1985-07-24
PCT/US1985/001401 WO1986000814A1 (en) 1984-07-24 1985-07-24 Adhesive transdermal dosage layer

Publications (4)

Publication Number Publication Date
FI861177A0 FI861177A0 (fi) 1986-03-20
FI861177A FI861177A (fi) 1986-03-20
FI85106B true FI85106B (fi) 1991-11-29
FI85106C FI85106C (sv) 1992-03-10

Family

ID=24541997

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861177A FI85106C (sv) 1984-07-24 1986-03-20 Förfarande för framställning av ett transdermalt doseringssystem

Country Status (11)

Country Link
US (1) US5186938A (sv)
EP (1) EP0190262B1 (sv)
JP (1) JPS61502760A (sv)
AT (1) ATE59302T1 (sv)
AU (1) AU576889B2 (sv)
DE (1) DE3581188D1 (sv)
FI (1) FI85106C (sv)
HK (1) HK94093A (sv)
MY (1) MY100249A (sv)
NO (1) NO171950C (sv)
WO (1) WO1986000814A1 (sv)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPS63503540A (ja) * 1986-05-29 1988-12-22 フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ 生物分解性ポリマー製の抗腫瘍性フィルム
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4818541A (en) * 1987-08-19 1989-04-04 Schering Corporation Transdermal delivery of enantiomers of phenylpropanolamine
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP2718433B2 (ja) * 1989-09-08 1998-02-25 シグナス インコーポレイテッド 経皮ドラッグデリバリーのための固体マトリックスシステム
US5204109A (en) * 1989-12-28 1993-04-20 Nitto Denko Corporation Percutaneous gel preparation
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
EP0436203B1 (en) * 1989-12-28 1996-04-03 Nitto Denko Corporation Percutaneous gel preparation
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
JPH04261119A (ja) * 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
ATE126434T1 (de) 1991-06-10 1995-09-15 Sanol Arznei Schwarz Gmbh Nitroglycerin-pflaster und verfahren zu seiner herstellung.
DE4229230C2 (de) * 1992-09-02 1997-01-16 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Pentetrazol als Wirkstoff
US5489624A (en) * 1992-12-01 1996-02-06 Minnesota Mining And Manufacturing Company Hydrophilic pressure sensitive adhesives
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
AU7568394A (en) * 1993-08-19 1995-03-14 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
AU5299996A (en) * 1995-02-23 1996-09-11 Cygnus, Inc. Water-soluble pressure-sensitive mucoadhesive
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
DE19706824C1 (de) 1997-02-21 1998-03-26 Lohmann Therapie Syst Lts Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
GB9704022D0 (en) * 1997-02-26 1997-04-16 York Rehabilitation Limited Protective barrier composition
US20020018754A1 (en) * 1999-03-15 2002-02-14 Paul Albert Sagel Shapes for tooth whitening strips
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
GB9714650D0 (en) * 1997-07-11 1997-09-17 Strakan Ltd Block copolymer
US6183770B1 (en) * 1999-04-15 2001-02-06 Acutek International Carrier patch for the delivery of agents to the skin
HUP0201620A3 (en) 1999-07-02 2003-02-28 Procter & Gamble Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
DE19940238A1 (de) 1999-08-25 2001-03-01 Lohmann Therapie Syst Lts Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten
EP1318843B1 (en) * 2000-09-19 2013-04-17 Henkel AG & Co. KGaA Acryl adhesive useful in transdermal drug delivery systems
US6709716B2 (en) * 2001-04-27 2004-03-23 3M Innovative Properties Company Microemulsion compositions and methods of making and using same
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7910641B2 (en) * 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20100021526A1 (en) * 2001-10-12 2010-01-28 Monosol Rx, Llc Ph modulated films for delivery of actives
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8017150B2 (en) * 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
JP4295467B2 (ja) 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
US6949240B2 (en) * 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
AU2003268015A1 (en) * 2002-07-22 2004-02-09 Kosmos Pharma Packaging and dispensing of rapid dissolve dosage form
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US20050019277A1 (en) * 2002-09-11 2005-01-27 The Procter & Gamble Company Tooth whitening products
US20070059351A1 (en) * 2003-10-17 2007-03-15 Murrell George A C Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
US20060286158A1 (en) * 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
US20070053966A1 (en) * 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US20060286159A1 (en) * 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
CA2588295C (en) 2004-11-23 2013-10-22 Neuromolecular Pharmaceuticals, Inc. Method and composition for administering an nmda receptor antagonist to a subject
PL1874282T3 (pl) 2005-04-06 2011-04-29 Adamas Pharmaceuticals Inc Sposoby i kompozycje do leczenia zaburzeń OUN
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
JP2009509535A (ja) * 2005-09-27 2009-03-12 アムニクス， インコーポレイテッド タンパク様薬剤およびその使用
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
CA2636026A1 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film lined pouch and method of manufacturing this pouch
US20070202155A1 (en) * 2006-02-03 2007-08-30 Cure Therapeutics, Inc. Low dose no donor-containing transdermal patch
US20070259026A1 (en) * 2006-04-20 2007-11-08 Robert Ang Vasodialating dressing for use with intravenous catheters
EP2063864A4 (en) * 2006-09-20 2012-03-14 Monosol Rx Llc EDIBLE WATER-SOLUBLE FILM CONTAINING FLAVOR-REDUCING AGENT
CN101534799A (zh) * 2006-09-29 2009-09-16 莫诺索尔克斯有限公司 膜埋入式包装及其制备方法
BRPI0815416A2 (pt) * 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
EP3178835B1 (en) 2009-02-03 2019-04-10 Amunix Pharmaceuticals, Inc. Extended recombinant polypeptides and compositions comprising same
LT2440241T (lt) 2009-06-08 2017-10-10 Amunix Operating Inc. Augimo hormonų polipeptidai ir jų gamybos bei panaudojimo būdai
JP5839597B2 (ja) 2009-06-08 2016-01-06 アムニクス オペレーティング インコーポレイテッド グルコース調節ポリペプチド並びにその作成及び使用方法
US8475832B2 (en) * 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
EP2470670A4 (en) 2009-08-24 2013-07-10 Amunix Operating Inc COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
US8741343B2 (en) 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
WO2011156711A1 (en) 2010-06-10 2011-12-15 Schobel Alexander M Nanoparticle film delivery systems
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
HUE046848T2 (hu) 2012-02-15 2020-03-30 Bioverativ Therapeutics Inc VIII. faktor készítmények és eljárások elõállításukra és alkalmazásukra
EP2822577B1 (en) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Recombinant factor viii proteins
EP2908798B1 (en) 2012-10-17 2018-08-22 The Procter and Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
JP6909203B2 (ja) 2015-08-03 2021-07-28 バイオベラティブ セラピューティクス インコーポレイテッド 第ｉｘ因子融合タンパク質及びそれらの製造方法及び使用方法
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
WO2018071656A1 (en) 2016-10-14 2018-04-19 Knowles Enterprises Inc. Formulations for treatment of migraines
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use
CN109453414A (zh) * 2018-09-26 2019-03-12 南阳市中心医院 一种肝胆外科术后抗感染的敷料

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3896789A (en) * 1974-06-10 1975-07-29 Riker Laboratories Inc Retinoic acid dipensing pressure sensitive dermotological tape
US4310509A (en) * 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
DE3005374A1 (de) * 1980-02-11 1981-08-20 Schering Ag Berlin Und Bergkamen, 1000 Berlin 3-desoxy-delta hoch 15 -steroide, verfahren zu ihrer herstellung sowie diese enthaltende pharmazeutische praeparate
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
JPS577414A (en) * 1980-06-14 1982-01-14 Nitto Electric Ind Co Ltd Preparation of plaster
JPS577409A (en) * 1980-06-14 1982-01-14 Nitto Electric Ind Co Ltd Plaster
JPS577413A (en) * 1980-06-14 1982-01-14 Nitto Electric Ind Co Ltd Plaster
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
JPS6038368B2 (ja) * 1981-09-12 1985-08-31 日東電工株式会社 貼付剤の製造方法
US4374164A (en) * 1981-12-14 1983-02-15 American Cyanamid Company High solids polymer resin coating composition containing amino resin cross-linking agent
US4608249A (en) * 1982-11-02 1986-08-26 Nitto Electric Industrial Co., Ltd. Hydrophilic therapeutic material

Also Published As

Publication number Publication date
EP0190262B1 (en) 1990-12-27
DE3581188D1 (de) 1991-02-07
EP0190262A1 (en) 1986-08-13
JPS61502760A (ja) 1986-11-27
JPH0440326B2 (sv) 1992-07-02
FI861177A0 (fi) 1986-03-20
AU576889B2 (en) 1988-09-08
HK94093A (en) 1993-09-17
NO171950B (no) 1993-02-15
FI85106C (sv) 1992-03-10
AU4676185A (en) 1986-02-25
MY100249A (en) 1990-07-12
FI861177A (fi) 1986-03-20
ATE59302T1 (de) 1991-01-15
WO1986000814A1 (en) 1986-02-13
NO861101L (no) 1986-03-20
US5186938A (en) 1993-02-16
NO171950C (no) 1993-05-26

Similar Documents

Publication Publication Date Title
FI85106B (fi) Foerfarande foer framstaellning av ett transdermalt doseringssystem.
US5730999A (en) Dermal therapeutic system made of a meltable poly (meth) acrylate
KR100920599B1 (ko) 작용기를 함유하지 않는 폴리아크릴레이트 접촉 결합 접착제에 기초한 경피 제제
US7638140B2 (en) Adhesive mixture for transdermal delivery of highly plasticizing drugs
EP2938335B1 (en) Multi-polymer compositions for transdermal drug delivery
US20150246006A1 (en) Transdermal systems having control delivery system
KR101017882B1 (ko) 가교형 피부용 점착제
JPH07138153A (ja) 有効薬剤の経皮供給
KR20020034985A (ko) 접착제
JPH10182440A (ja) 皮膚もしくは経皮の治療系のための付着−及び接合剤及びその使用
CA2430857C (en) Percutaneous absorption-type pharmaceutical preparation and process for producing the same
ES2702879T3 (es) Composiciones de anfetamina transdérmicas estables y métodos de fabricación
FI118885B (sv) Skopolaminplåster
JPS60185713A (ja) 経皮吸収性製剤及びその製法
WO2000051575A1 (en) Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
KR20040033082A (ko) 에페리손, 톨페리손 또는 그것들의 염을 포함하는경피흡수제제
CA1269326A (en) Adhesive transdermal dosage layer
JP3618970B2 (ja) 貼付剤
JPS5846959A (ja) 貼付剤の製造方法
JPH07116025B2 (ja) 貼付剤
JPH0339488B2 (sv)
IE852036L (en) Adhesive bilayer transdermal dosage system for sustained¹release of pharmaceuticals.
DK169202B1 (da) Klæbende transdermalt tolags-doseringssystem og tilsvarende klæbende transdermalt doseringslag samt fremgangsmåde til fremstilling af et sådant lag
KR20010074687A (ko) 글리세롤트리니트레이트 함유 조성물, 상기 조성물의제조방법 및 용도
JPH0529004B2 (sv)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: KEY PHARMACEUTICALS, INC.